1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 4: Characteristics of participants included in the assessment of concordance between prenatal prognosis and postnatal neurodevelopmental outcome
Characteristic (n = 104) GA <25 Weeks (n = 50) GA ≥25 Weeks (n = 54)
GA at fetal MR imaging (range)  (median) (IQR) (wk) 19.00–39.43 (26.1 [21.8, 31.9]) 19.00–24.43 (21.7 [21.0, 23.0]) 25.00–39.43 (31.9 [29.6–34.0])
Maternal age at fetal MR imaging  (range) (median) (IQR) (yr) 16.00–41.00 (31.0 [28.0–33.0]) 16.00–41.00 (30.0 [28.0–32.0]) 17.00–41.00 (31.0 [28.0–34.0])
Age at postnatal visit (range) (median) (IQR) (yr) 1.00–10.42 (3.0 [1.9–5.9]) 1.00–8.92 (2.8 [1.7–5.1]) 1.00–10.42 (3.8 [2.0–6.0])
Brain region (No.) (%) 
 Ventriculomegaly 32 (30.8%) 17 (34.0%) 15 (27.8%)
  Mild 20 (19.2%) 12 (24.0%) 8 (14.8%)
  Moderate 5 (4.8%) 3 (6.0%) 2 (3.7%)
  Severe 7 (6.7%) 2 (4.0%) 5 (9.3%)
 Posterior fossa 19 (18.3%) 7 (14.0%) 12 (22.2%)
 Corpus callosum 11 (10.6%) 2 (4.0%) 9 (16.7%)
 Sulcation/migration 8 (7.7%) 5 (10.0%) 3 (5.6%)
 Normal 28 (26.9%) 18 (36.0%) 10 (18.5%)
 Space 4 (3.8%) 1 (2.0%) 3 (5.6%)
 Vascular anomaly 1 (1.0%) 0 (0.0%) 1 (1.9%)
 Hemorrhage 1 (1.0%) 0 (0.0%) 1 (1.9%)